These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18565693)

  • 41. Treating alcohol and drug use disorders.
    McCarty D; Capoccia V; Chalk M
    Health Aff (Millwood); 2013 Mar; 32(3):630. PubMed ID: 23459745
    [No Abstract]   [Full Text] [Related]  

  • 42. Reducing waiting time for substance abuse treatment does not reduce attrition.
    Alterman AI; Bedrick J; Howden D; Maany I
    J Subst Abuse; 1994; 6(3):325-32. PubMed ID: 7703709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment.
    Watkins KE; Hunter SB; Wenzel SL; Tu W; Paddock SM; Griffin A; Ebener P
    Am J Drug Alcohol Abuse; 2004 Nov; 30(4):749-64. PubMed ID: 15624547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use.
    Wiercigroch D; Sheikh H; Hulme J
    Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):4. PubMed ID: 31931831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An experimental test of retention in residential and outpatient programs.
    Bell DC; Williams ML; Nelson R; Spence RT
    Am J Drug Alcohol Abuse; 1994 Aug; 20(3):331-40. PubMed ID: 7977218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of public sector substance abuse treatment: comparison of a managed care approach to a traditional public sector system.
    Beattie MC; Hu TW; Li R; Bond JC
    J Behav Health Serv Res; 2005; 32(4):409-29. PubMed ID: 16215450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Applicability, duration, and sociomedical course of rehabilitation of alcohol dependency. Current results and perspectives from the insurers' point of view].
    Köhler J; Grünbeck P; Soyka M
    Nervenarzt; 2007 May; 78(5):536, 538-41, 543-6. PubMed ID: 16791548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction effects of client and treatment program characteristics on retention: an exploratory analysis using hierarchical linear models.
    Chou CP; Hser YI; Anglin MD
    Subst Use Misuse; 1998 Sep; 33(11):2281-301. PubMed ID: 9758014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An initial evaluation of the psychosocial dimensions of the American Society of Addiction Medicine criteria for inpatient versus intensive outpatient substance abuse rehabilitation.
    McKay JR; Cacciola JS; McLellan AT; Alterman AI; Wirtz PW
    J Stud Alcohol; 1997 May; 58(3):239-52. PubMed ID: 9130215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs.
    Broome KM; Flynn PM; Simpson DD
    Health Serv Res; 1999 Aug; 34(3):791-806. PubMed ID: 10445903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment.
    Schroder R; Sellman D; Frampton C; Deering D
    Drug Alcohol Rev; 2009 Nov; 28(6):663-8. PubMed ID: 19930021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methadone dosage and retention: an examination of the 60 mg/day threshold.
    Brady TM; Salvucci S; Sverdlov LS; Male A; Kyeyune H; Sikali E; DeSale S; Yu P
    J Addict Dis; 2005; 24(3):23-47. PubMed ID: 16186081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Private substance abuse treatments: are some programs more effective than others?
    McLellan AT; Grissom GR; Brill P; Durell J; Metzger DS; O'Brien CP
    J Subst Abuse Treat; 1993; 10(3):243-54. PubMed ID: 8391086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alcohol use outcomes and heavy drinking at 4-5 years among a treatment sample of drug misusers.
    Gossop M; Browne N; Stewart D; Marsden J
    J Subst Abuse Treat; 2003 Oct; 25(3):135-43. PubMed ID: 14670519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using NIATx strategies to implement integrated services in routine care: a study protocol.
    Ford JH; Osborne EL; Assefa MT; McIlvaine AM; King AM; Campbell K; McGovern MP
    BMC Health Serv Res; 2018 Jun; 18(1):431. PubMed ID: 29884164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of diagnosis and treatment among late-middle-aged and older substance abuse patients.
    Moos RH; Mertens JR; Brennan PL
    J Stud Alcohol; 1993 Jul; 54(4):479-87. PubMed ID: 8393499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in the development of alcohol and drug treatment services in Ontario: a replication and extension of a previous study.
    Rush B; Tyas S
    Addiction; 1993 Feb; 88(2):183-91. PubMed ID: 8220056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Community-based psychiatric treatment of patients with alcohol and substance related disorders -- a new concept].
    Kurz M
    Wien Med Wochenschr; 2006 Feb; 156(3-4):94-101. PubMed ID: 16699940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A population based perspective of twenty years of specialized ambulatory treatment for alcohol use disorders in publicly financed clinics. Barcelona 1996-2015.
    Villalbí JR; Espelt A; Suelves JM; Bosque-Prous M; Bartroli M; Brugal MT
    J Subst Abuse Treat; 2018 Sep; 92():11-16. PubMed ID: 30032939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Moment-by-Moment in Women's Recovery (MMWR): Mindfulness-based intervention effects on residential substance use disorder treatment retention in a randomized controlled trial.
    Black DS; Amaro H
    Behav Res Ther; 2019 Sep; 120():103437. PubMed ID: 31419610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.